Therapeutic Potential of Citronella Essential Oil: A Review.

Sharma R et al (2019).

Curr Drug Discov Technol.

DOI:

10.2174/1570163815666180718095041

PubMed:

30019646

Biological Activities and Safety of Citrus spp. Essential Oils.

Dosoky NS and Setzer WN (2018).

Int J Mol Sci.

DOI:

10.3390/ijms19071966

PubMed:

29976894

Panax notoginseng for Inflammation-Related Chronic Diseases: A Review on the Modulations of Multiple Pathways.

Xu Y et al (2018).

Am J Chin Med.

DOI:

10.1142/S0192415X18500519

PubMed:

29976083

MicroRNAs in Marchantia polymorpha.

Lin SS and Bowman JL (2018).

New Phytol.

DOI:

10.1111/nph.15294

PubMed:

29959894

Dl-3-n-Butylphthalide (NBP): A Promising Therapeutic Agent for Ischemic Stroke.

Ischemic stroke is a major cause of morbidity and mortality, with few treatment options. Recombinant tissue plasminogen activator (rtPA) is the only FDA-approved drug, but its strict therapeutic window limits its use. Dl-3-n-Butylphthalide (NBP), a synthetic compound derived from seeds of the Apium graveolens plant, has shown promise in treating ischemic stroke in multiple clinical studies. NBP has multiple mechanisms of action, including anti-oxidant, anti-inflammatory, anti-apoptotic, and anti-thrombotic effects, as well as protecting mitochondria. This review highlights the potential of NBP as a powerful multi-target therapy for ischemic stroke.

Wang S et al (2018).

CNS Neurol Disord Drug Targets.

DOI:

10.2174/1871527317666180612125843

PubMed:

29895257

Trichosanthis Fructus: botany, traditional uses, phytochemistry and pharmacology.

Yu X et al (2018).

J Ethnopharmacol.

DOI:

10.1016/j.jep.2018.05.034

PubMed:

29842965

Phytochemistry, bioactivity: suggestion of Ceratonia siliqua L. as neurodegenerative disease therapy.

Lakkab I et al (2018).

J Complement Integr Med.

DOI:

10.1515/jcim-2018-0013

PubMed:

29813031

Grifola frondosa polysaccharide: a review of antitumor and other biological activity studies in China.

He Y et al (2018).

Discov Med.

PubMed:

29723488